No Data
Yue Jiangxi Wannianqing (301111.SZ): Sangqi hypoglycemic tablets are proposed to be selected for centralized bulk purchasing.
On January 2, Gelonghui reported that Guangdong Wannianqing Pharmaceutical Co., Ltd. (301111.SZ) recently participated in the centralized procurement work of the National Chinese Patent Medicine Procurement Alliance. According to the "Proposed Selected Results of the Centralized Bulk Procurement of the National Chinese Patent Medicine Procurement Alliance" issued by the Hubei Medical Insurance Service Platform on December 30, 2024, the company's product, Shensi Jiangtang Tablets, is proposed to be selected for this centralized bulk procurement. This proposed selected product, Shensi Jiangtang Tablets, is the company's exclusive formulation and is included in the National Medical Insurance and National Basic Drug List. The sales revenue of the company's Shensi Jiangtang Tablets for the 2023 fiscal year was 0.113 billion yuan, accounting for the company's 202...
Jiangxi Wannianqing Cement (000789.SZ): plans to register and issue corporate bonds not exceeding 2 billion yuan.
Gelonghui reported on December 30 that Jiangxi Wannianqing Cement (000789.SZ) announced that the company will hold the second extraordinary meeting of the tenth Board of Directors and the second extraordinary meeting of the tenth Supervisory Board on December 27, 2024. The meetings approved the proposal regarding the proposed registration and issuance of corporate bonds, to enhance the company's capital security capacity, further broaden financing channels, and optimize the financing structure. The company agrees to apply to the Shenzhen Securities Exchange for public issuance of corporate bonds after being registered with the China Securities Regulatory Commission. The issuance amount of these corporate bonds will not exceed 2 billion yuan (including 2 billion yuan), with a specific issuance scale to be determined.
Jiangxi Wannianqing Cement (000789.SZ): Jiangxi Cement has cumulatively increased its shareholding by 0.87%.
On December 26, Gelonghui announced that Jiangxi Wannianqing Cement (000789.SZ) increased its shareholding through the Exchange trading system by a cumulative 6,905,400 shares from June 25 to December 24, 2024, accounting for 0.87% of the total share capital of Wannianqing. The amount for the increased shares was 32,374,166.00 yuan. After this increase, Jiangxi Wannianqing Cement holds 354,385,404 shares of the company, accounting for 44.44% of the total share capital.
Guangdong Jiangxi Wannianqing Cement (301111.SZ): 89.8615 million shares of restricted shares will be lifted on December 9th.
Galaxy Great Wall December 5th | Guangdong Jiangxi Wannianqing Cement (301111.SZ) announced a cautionary announcement on the partial public offering of previously issued shares that have been listed for trading. The number of shareholders with restricted shares lifted this time totals 3, with the quantity of restricted shares released being 89.86152 million shares, accounting for 56.16% of the company's total share capital. The lock-up period is 36 months from the date of the company's initial public offering and listing. The shares released from restrictions will start trading on December 9, 2024 (Monday).
Wan Nianqing: Report for the third quarter of 2024
Jiangxi Wannianqing Cement (000789.SZ) released its performance for the first three quarters, with a net income of 6.9781 million yuan, a year-on-year decrease of 97.74%.
Jiangxi Wannianqing Cement (000789.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 4...
